A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...
Please provide your email address to receive an email when new articles are posted on . Ezetimibe conferred no increased risk for new-onset diabetes among IMPROVE-IT participants. The findings were ...
Please provide your email address to receive an email when new articles are posted on . A combination of obicetrapib and ezetimibe further lowered LDL in statin-treated patients with dyslipidemia. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results